Experimental and theoretical investigation of water-soluble silicon(IV) phthalocyanine and its interaction with bovine serum albumin
- PMID: 33558997
- DOI: 10.1007/s00775-021-01848-w
Experimental and theoretical investigation of water-soluble silicon(IV) phthalocyanine and its interaction with bovine serum albumin
Abstract
Photodynamic therapy (PDT) has drawn a great scientific attention to cancer treatment over the last decades. However, the bottleneck for the PDT is to find good photosensitizers (PSs) with greater water solubility, no aggregation, and fast discharge from the body. Therefore, there are still a big scientific desire for the synthesizing new rational PSs for treatment of cancer by PDT technique. In favor of improving the competence of PDT, an axially bis[4-(diphenylamino-1,1'-biphenyl-4-ol)] substituted silicon(IV) phthalocyanine (3) was converted to its water-soluble quaternized derivative (3Q). Their structures were fully characterized by single-crystal X-ray diffraction, elemental analysis, and different spectroscopic methods such as FT-IR, UV-Vis, MALDI-TOF, and 1H-NMR. The photophysical properties such as fluorescence quantum yields and lifetimes, and the photochemical properties such as singlet oxygen generation of both phthalocyanines were investigated. Ground and excited-state calculations were performed to explain the observed electronic absorption spectra. The addition of the 4-diphenylamino-1,1'-biphenyl-4-ol groups on the axially positions of the silicon(IV) phthalocyanine increased the singlet oxygen quantum yield from 0.15 to around 0.20. Especially quaternized compound 3Q showed high singlet oxygen quantum yield of 0.26 in water solution. In addition, a spectroscopic investigation of the binding behavior of the quaternized silicon (IV) phthalocyanine complex to bovine serum albumin (BSA) is also studied in this work, confirming the possible interaction. Further theoretical calculations were carried out to find out the plausible-binding regions of the BSA protein. Axially bis[4-(diphenylamino-1,1'-biphenyl-4-ol)] substituted silicon(IV) phthalocyanine (3) was converted to its quaternized water soluble derivative (3Q). The photophysical properties such as fluorescence quantum yields and lifetimes, and the photochemical properties such as singlet oxygen generation of both phthalocyanines were investigated. In addition, a spectroscopic investigation of the binding behavior of the quaternized silicon (IV) phthalocyanine complex to bovine serum albumin (BSA) is also studied in this work, confirming the possible interaction. Further theoretical calculations were carried out to find out the plausible binding regions of the BSA protein.
Keywords: BSA/DNA binding; Photodynamic therapy; Phthalocyanine; Singlet oxygen; Water soluble.
Similar articles
-
Photophysicochemical, calf thymus DNA binding and in vitro photocytotoxicity properties of tetra-morpholinoethoxy-substituted phthalocyanines and their water-soluble quaternized derivatives.J Biol Inorg Chem. 2017 Dec;22(8):1251-1266. doi: 10.1007/s00775-017-1499-3. Epub 2017 Oct 19. J Biol Inorg Chem. 2017. PMID: 29052049
-
Axially substituted silicon(IV) phthalocyanine and its quaternized derivative as photosensitizers towards tumor cells and bacterial pathogens.Bioorg Med Chem. 2017 Oct 15;25(20):5415-5422. doi: 10.1016/j.bmc.2017.07.065. Epub 2017 Aug 1. Bioorg Med Chem. 2017. PMID: 28807573
-
The water soluble axially disubstituted silicon phthalocyanines: photophysicochemical properties and in vitro studies.J Biol Inorg Chem. 2017 Aug;22(6):953-967. doi: 10.1007/s00775-017-1473-0. Epub 2017 Jun 14. J Biol Inorg Chem. 2017. PMID: 28616663
-
A comprehensive review on singlet oxygen generation in nanomaterials and conjugated polymers for photodynamic therapy in the treatment of cancer.Nanoscale. 2024 Feb 15;16(7):3243-3268. doi: 10.1039/d3nr05801h. Nanoscale. 2024. PMID: 38265094 Review.
-
Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy.Curr Drug Metab. 2012 Oct;13(8):1119-22. doi: 10.2174/138920012802850074. Curr Drug Metab. 2012. PMID: 22380016 Review.
Cited by
-
Water-soluble phthalocyanine photosensitizers for photodynamic therapy.Turk J Chem. 2023 Sep 26;47(5):837-863. doi: 10.55730/1300-0527.3583. eCollection 2023. Turk J Chem. 2023. PMID: 38173755 Free PMC article.
References
-
- Leznoff CC, Lever ABP (1989, 1993, 1996) In Phthalocyanines: properties and applications, vol 1–4. VCH Publishers, New York
-
- Durmuş M, Ahsen V (2010) Water-soluble cationic gallium(III) and indium(III) phthalocyanines for photodynamic therapy. J Inorg Biochem 104:297–309 - PubMed
-
- Hu M, Brasseur N, Yıldız SZ, Van Lier JE, Leznoff CC (1998) Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy. J Med Chem 41:1789–1802 - PubMed
-
- Robertson CA, Evans DH, Abrahamse H (2009) Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B Biol 96:1–8
-
- Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380–387 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous